SEC Filing Details

Document Details

Form
3
Filing Date
Jan 21, 2022
Document Date
Jan 12, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
WINKELRIED JON